Anthera Pharmaceuticals Inc (ANTH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2018 | 12-2017 | 09-2017 | 06-2017 | 03-2017 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -7,724 | -26,874 | -17,201 | -10,894 | -11,207 |
| Depreciation Amortization | 161 | 281 | 246 | 205 | 45 |
| Accounts receivable | 0 | N/A | 0 | 0 | -100 |
| Accounts payable and accrued liabilities | -97 | -2,950 | -3,773 | -2,809 | -2,023 |
| Other Working Capital | -1,832 | -5,043 | -6,558 | -7,308 | -4,853 |
| Other Operating Activity | 111 | -2,314 | -3,354 | -3,636 | 3,809 |
| Operating Cash Flow | $-9,381 | $-36,900 | $-30,640 | $-24,442 | $-14,329 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | 358 | N/A | N/A | N/A | N/A |
| Investing Cash Flow | $358 | $N/A | $0 | $0 | $0 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 14,913 | 18,253 | 15,873 | 14,750 | 14,138 |
| Financing Cash Flow | $14,913 | $18,253 | $15,873 | $14,750 | $14,138 |
| Beginning Cash Position | 2,196 | 20,843 | 20,843 | 20,843 | 20,843 |
| End Cash Position | 8,086 | 2,196 | 6,076 | 11,151 | 20,652 |
| Net Cash Flow | $5,890 | $-18,647 | $-14,767 | $-9,692 | $-191 |
| Free Cash Flow | |||||
| Operating Cash Flow | -9,381 | -36,900 | -30,640 | -24,442 | -14,329 |
| Free Cash Flow | -9,381 | -36,900 | -30,640 | -24,442 | -14,329 |